Itacitinib for the Treatment of Bronchiolitis Obliterans Syndrome After Donor Hematopoietic Cell Transplant

NCT04239989 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

8

Enrollment

OTHER

Sponsor class

Stopped \<75% participation

Conditions

Bronchiolitis Obliterans

Interventions

DRUG: Itacitinib
DRUG: Itacitinib Adipate

Sponsor

M.D. Anderson Cancer Center